3 AI Stocks Helping Companies Cut Costs With Software And Cloud Tools

Central banks are still talking tough on inflation, and investors are watching interest rate paths closely. That kind of backdrop keeps attention on businesses that help other companies work smarter and cut costs. Artificial intelligence is a big part of that story. This article looks at three stocks from an AI screener focused on chips, software, and cloud tools that plug directly into the ChatGPT and AI build out.

The stocks covered next are just a small sample of the opportunities tied to the build out of AI chips, software, and cloud tools. The wider screen surfaced 15 more companies with equally compelling narratives that are not included in this article.

To go straight to the source and analyze, filter, and identify which ideas best fit your own thesis, head into the Artificial Intelligence/ AI Stocks screener.

Cerillion (AIM:CER)

Cerillion is a London headquartered software company that supplies telecom operators and subscription businesses with billing, charging and customer management tools, with a clear AI link through its Business Insights analytics platform and AI driven Enterprise Product Catalogue. The business is split across Software, which generated about £22.6 million in revenue, Services at about £17.8 million, and Other income of about £2 million. AI features are embedded within a broader recurring software and services model. Cerillion has a market cap of about £282.4 million.

Cerillion gives you direct exposure to AI in telecoms through its Business Insights analytics platform and AI infused BSS/OSS suite, which telecom operators use to analyse customer behaviour and automate product launches. That AI angle is attracting attention. However, the stock is still priced on a mid range software multiple despite this specialist positioning. At the same time, the latest half year results showed revenue and earnings down, so you need to weigh the AI growth story against near term softness in reported numbers and governance questions around board independence. For investors willing to do the work, the mix of AI driven telecom software, strong margins and a recent dividend increase could make Cerillion a company worth a closer look.

Cerillion’s AI telecom story looks like it could be stronger than its recent numbers suggest, especially with that dividend increase grabbing attention. Yet one key issue still hangs over the thesis in the 4 key rewards and 1 important major warning sign

Bytes Technology Group (LSE:BYIT)

Bytes Technology Group is a UK based IT solutions provider that helps organisations move to the cloud, secure their systems, and roll out AI enabled software, including tools to deploy large language models and automation across Digital Workspace, Hybrid Infrastructure, and Public Cloud services. The company reports £220.6 million of revenue from its IT Solutions Provider segment, with most activity in the UK and smaller contributions from Europe and the rest of the world. Bytes Technology Group has a market cap of about £958 million.

Investors looking at the AI and ChatGPT build out may find Bytes Technology Group worth some attention. The company helps enterprise and public sector customers adopt AI ready cloud platforms and automation tools, while also earning from more traditional software and hardware reselling. That mix supports solid profitability and a high return on equity, but recent negative earnings growth, changes to Microsoft incentives and a UBS downgrade in July raise questions about how smooth the next phase will be. For readers willing to look past the headlines, the real interest lies in how its AI centric services, cybersecurity push and boardroom refresh could shape the next few years of this £958 million stock.

Bytes Technology Group sits at an interesting crossroads. Earnings headlines and changing Microsoft incentives may be masking where the AI opportunity really lies. Step into the analysis report for Bytes Technology Group to see what could be quietly building beneath the surface.

AdvancedAdvT (AIM:ADVT)

AdvancedAdvT is a London based software company focused on business solutions and healthcare compliance, with a clear AI link through its AI based healthcare intelligence compliance and accreditation software that analyzes clinical and operational data. The company reports about £53 million of revenue from Internet Software & Services, primarily in the UK, and has a market cap of about £231 million.

AdvancedAdvT gives you a pure software route into healthcare AI, where its compliance and accreditation tools use machine learning to comb through hospital and clinic data for risks and quality issues. Revenue of £53.4 million and net income of £4.61 million show a business that is generating cash, but a recent earnings decline, margin pressure and a high P/E multiple mean expectations for that AI product set are already reflected in the valuation. With an AGM on 12 August 2026 that could shed more light on AI priorities, this is a company where the key question may be how quickly healthcare clients adopt those AI driven tools and how that affects profitability.

AdvancedAdvT’s healthcare AI engine is already turning real hospital data into compliance insights, yet the current P/E suggests expectations are running hot. The real twist sits inside the 2 key rewards and 2 important warning signs

Curious About The Next Big Alternatives

Fresh ideas can move quickly. The next breakout stock stories might still be under the radar for now. Scan these curated lists before the momentum gets fully caught.

• Spot income opportunities that aim to keep paying while others drop by scanning a curated group of 6 dividend fortresses that may help anchor a long term portfolio.
• Track future facing materials companies by scanning a focused group of 28 best rare earth metal stocks linked to the electrification and advanced manufacturing build out.
• Scan a hand picked 7 resilient stocks with low risk scores and look for stocks where resilient balance sheets and milder risk profiles could help steady returns when momentum changes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com